How we're advancing personalized treatment for ALS and neurodegenerative diseases.
We generate neurons directly from each patient's cells to build personalized disease models. These models allow rapid testing of potential treatments tailored to each individual's unique disease mechanisms.
Using automated high-throughput assays, we identify treatments tailored to individual disease profiles and genetic backgrounds. Our platform screens thousands of compounds to find the right match for each patient.
Once we identify personalized treatments, we work closely with patients and their care teams to help bring these therapies back to them. Our goal is to close the gap between laboratory discovery and patient care.
Your donation directly funds personalized disease modeling and drug screening for ALS patients.